2023
DOI: 10.1016/j.rasd.2023.102131
|View full text |Cite
|
Sign up to set email alerts
|

Effectiveness of deep brain stimulation in refractory and drug-resistant aggressiveness in autism spectrum disorder

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
15
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
2

Relationship

2
4

Authors

Journals

citations
Cited by 8 publications
(16 citation statements)
references
References 67 publications
1
15
0
Order By: Relevance
“…The most frequent comorbidities were medication-resistant abnormal movements (32), psychiatric disorders (28,30,(32)(33)(34), neurodevelopmental syndromes and diseases (6, 25-27, 31, 35) and drug abuse (34). Although in 4 registries, no comorbidities were reported (22)(23)(24)33). The main clinical reason for subjecting patients to DBS was to reduce uncontrolled aggression.…”
Section: Results Of the Bibliographic Searchmentioning
confidence: 99%
See 3 more Smart Citations
“…The most frequent comorbidities were medication-resistant abnormal movements (32), psychiatric disorders (28,30,(32)(33)(34), neurodevelopmental syndromes and diseases (6, 25-27, 31, 35) and drug abuse (34). Although in 4 registries, no comorbidities were reported (22)(23)(24)33). The main clinical reason for subjecting patients to DBS was to reduce uncontrolled aggression.…”
Section: Results Of the Bibliographic Searchmentioning
confidence: 99%
“…In contrast, a signi cant number of publications were identi ed in South America, with a concentration of interventions performed in Colombia. In this country, there are several experiences of DBS application in pHypN in intractable aggressiveness in children and adolescents with epilepsy (21,25,27), ASD and ID (22)(23)(24)26). Europe is the second continent where DBS has been used the most.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…As well, the role of motivation in memory of the children with ASD has been discussed in many studies (Dovis et al, 2012;Gabig, 2008;Hilton et al, 2014;Joseph et al, 2005;Stahmer et al, 2022). This is in the case that, resistant to pharmacological treatment, is observed in many cases of autism (Benedetti-Isaac et al, 2023). Since motivation has an underlying role in memory, determining the impact of any cognitive programs to increase performance in memory can also determine its impact on other behaviors and performance (Ozonoff & Strayer, 2001;Sigelman & Rider, 2014).…”
Section: Introductionmentioning
confidence: 99%